| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |